Braxia Scientific reports positive early results from Phase 2 psilocybin-assisted depression therapy

Subscribers:
56,400
Published on ● Video Link: https://www.youtube.com/watch?v=ed3ukfdG-iI



Duration: 4:55
1,236 views
0


Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company is reporting preliminary results from the Phase 2 randomized clinical trial to evaluate the feasibility, safety, tolerability and efficacy of multidose psilocybin-assisted therapy for treatment-resistant depression.
Dr McIntyre told Proactive the study showed clinically meaningful improvements in depression severity. Complete analysis of antidepressant efficacy and secondary outcomes pending; this trial will be completed by December, 2022, at which point the full analysis will be completed and submitted for publication.




Other Videos By Proactive Investors


2022-06-14FTSE shrugged off another torrid day on US markets but UK inflation concerns remain
2022-06-14discoverIE sets for significant organic progress, further acquisitions expected too
2022-06-14OnTheMarket Plc “delighted” with full year results
2022-06-14Medallion Metals welcomes 79% upgrade to resource at Kundip
2022-06-14Blu Horseshoe to provide investors with more opportunities in the secondary market space
2022-06-14Bass Oil kicks off commercialisation study for Kiwi gas discovery
2022-06-14Great Boulder reports high grade gold in first two RC holes at Ironbark
2022-06-13Northam Resources talks ASX listing and plans for its nickel-copper-PGE & gold assets
2022-06-13Australian Potash Ltd aiming for the top end of the sulphate of potash price spectrum
2022-06-13Gold Terra Resources sees very good results from three holes at Mispickel area in Yellowknife
2022-06-13Braxia Scientific reports positive early results from Phase 2 psilocybin-assisted depression therapy
2022-06-13Ortho Regenerative Technologies activates half of clinical sites in rotator cuff repair trial
2022-06-13Cypress Development Corp reaches significant milestones at company’s Lithium facility in Nevada
2022-06-13Digbee addresses the 'key pillars' needed to raise mining investor's confidence in ESG reporting
2022-06-13It’s a “very exciting” time for Faron Pharmaceutical as AML study advances
2022-06-13Alkaline Fuel Cell Power unveils PWWR Flow Brand for combined heat and power (CHP) division
2022-06-13Goodbody Health discusses its switch to a listing in London
2022-06-13Aya Gold & Silver begins 7,500 meter drill program at its Boumadine project in Morocco
2022-06-13Great Western Mining says Olympic Gold summer drilling is “looking pretty good”
2022-06-13Mercia Asset's COO discusses early stage investing
2022-06-13CentralNic boss says 'biggest risk is we'll be acquired'



Tags:
Investors
investing
investor
economy
stocks
stock market
ftse100
nasdaq
nyse
cse
tsx
tsx-v
otc market
finance
banking
wealth management
asset management
wall street
economics
mining
oil and gas
energy
precious metals
biotech
health
pharma
pharamceutical
cbd
cryptocurrency
bitcoin
blockchain
cannabidoil
cannabis stock
Proactive
ProactiveInvestors
Proactive Investors
shares
trading
money
business
china
china economy
USA
US Economy
EU
European Union
Brexit
YouTube
How To